Abstract
During heat sterilization of peritoneal dialysis solutions, glucose is partially transformed into glucose degradation products (GDPs), which significantly reduce the biocompatibility of these medicinal products. Targeted α-dicarbonyl screening identified glyoxal, methylglyoxal, 3-deoxyglucosone, 3,4-dideooxyglucosone-3-ene, glucosone, and 3-deoxygalactosone as the major six GDPs with α-dicarbonyl structure. In the present study, an ultra-high-performance liquid chromatography method was developed which allows the separation of all relevant α-dicarbonyl GDPs within a run time of 15 min after derivatization with o-phenylenediamine. Hyphenated diode array detection/tandem mass spectrometry detection provides very robust quantification and, at the same time, unequivocal peak confirmation. Systematic evaluation of the derivatization process resulted in an optimal derivatization period that provided maximal derivatization yield, minimal de novo formation (uncertainty range ±5%), and maximal sample throughput. The limit of detection of the method ranged from 0.13 to 0.19 μM and the limit of quantification from 0.40 to 0.57 μM. Relative standard deviations were below 5%, and recovery rates ranged between 91% and 154%, dependent on the type and concentration of the analyte (in 87 out of 90 samples, recovery rates were 100 ± 15%). The method was then applied for the analysis of commercial peritoneal dialysis fluids (nine different product types, samples from three lots of each).
Similar content being viewed by others
References
Sharma A, Blake PG (2007) Peritoneal dialysis. In: Brenner BM (ed) Brenner and Rector’s the kidney. Elsevier Saunders, Philadelphia, pp 2007–2037
Ledebo I, Wieslander A, Kjellstrand P (2000) Can we prevent the degradation of glucose in peritoneal dialysis solutions? Perit Dial Int 20(suppl 2):S48–S51
Frischmann M, Spitzer J, Fünfrocken M, Mittelmaier S, Deckert M, Fichert T, Pischetsrieder M (2009) Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids. Biomed Chromatogr 23(8):843–851
Tauer A, Knerr T, Niwa T, Schaub TP, Lage C, Passlick-Deetjen J, Pischetsrieder M (2001) In vitro formation of N[epsilon]-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis. Biochem Biophys Res Comm 280(5):1408–1414
Mahiout A, Ehlerding G, Brunkhorst R (1996) Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. Nephrol Dial Transplant 11(suppl 5):2–6
Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S (1999) Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14(6):1541–1549
Vriese AS (2005) The John F. Maher recipient lecture 2004: rage in the peritoneum. Perit Dial Int 25(1):8–11
Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A (2000) Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 11(4):729–739
Morgan LW, Wieslander A, Davies M, Horiuchi T, Ohta Y, Beavis MJ, Craig KJ, Williams JD, Topley N (2003) Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int 64(5):1854–1866
Lee D-H, Choi S-Y, Ryu H-M, Kim C-D, Park S-H, Chung H-Y, Kim I-S, Kim Y-L (2009) 3,4-Dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells. Perit Dial Int 29(1):44–51
Tomo T, Okabe E, Yamamoto T, Namoto S, Iwashita T, Matsuyama K, Kadota J, Nasu M (2005) Synergistic cytotoxicity of acidity and 3,4-dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid. Ther Apher Dial 9(2):182–187
Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen F-D, Bro S, Friedberg M, Wieslander A (2001) Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59(1):348–357
Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J (2004) The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66(1):408–418
Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Ahn C, Kim MJ, Shin SK (2005) Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance). Perit Dial Int 25(3):248–255
Mortier S, Faict D, Lameire NH, Vriese AS (2005) Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 67(4):1559–1565
Mittelmaier S, Fünfrocken M, Fenn D, Fichert T, Pischetsrieder M (2010) Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS. J Chromatogr B Analyt Technol Biomed Life Sci 878(11–12):877–882
Mittelmaier S, Fünfrocken M, Fenn D, Pischetsrieder M (2011) 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation. Anal Bioanal Chem 399(4):1689–1697
Nilsson-Thorell CB, Muscalu N, Andren AH, Kjellstrand PT, Wieslander AP (1993) Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 13(3):208–213
Linden T, Forsback G, Deppisch R, Henle T, Wieslander A (1998) 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 18(3):290–293
Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A (2002) 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 62(2):697–703
Glomb MA, Tschirnich R (2001) Detection of α-dicarbonyl compounds in Maillard reaction systems and in vivo. J Agric Food Chem 49(11):5543–5550
Anet EFLJ (1961) Degradation of carbohydrates. II. Action of acid and alkali on 3-deoxyhexosones. Aust J Chem 14:295–301
Erixon M, Wieslander A, Linden T, Carlsson O, Forsback G, Svensson E, Jonsson JA, Kjellstrand P (2006) How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int 26(4):490–497
Erixon M, Linden T, Kjellstrand P, Carlsson O, Ernebrant M, Forsback G, Wieslander A, Jonsson JA (2004) PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization. Perit Dial Int 24(4):392–398
Kjellstrand P, Erixon M, Wieslander A, Linden T, Martinson E (2004) Temperature: the single most important factor for degradation of glucose fluids during storage. Perit Dial Int 24(4):385–391
Acknowledgements
The study was supported by Fresenius Medical Care Deutschland GmbH, Germany. We thank the Deutsche Forschungsgemeinschaft for their contribution to the applied UHPLC/MSMS unit.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mittelmaier, S., Fünfrocken, M., Fenn, D. et al. Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS. Anal Bioanal Chem 401, 1183–1193 (2011). https://doi.org/10.1007/s00216-011-5195-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-5195-9